Literature DB >> 27923660

Highly expressed lncRNA CCND2-AS1 promotes glioma cell proliferation through Wnt/β-catenin signaling.

Hua Zhang1, Dai-Lin Wei2, Long Wan3, Shao-Feng Yan1, Yan-Hui Sun4.   

Abstract

Glioma is the most common and aggressive primary brain tumor in adults. Long-non coding RNAs (lncRNAs) have been recently shown to play important roles in regulating numerous biological processes both in physiologic and pathologic condition. However, the role of lncRNAs in glioma remains largely unknown. In this study, we firstly found that lncRNA CCND2-AS2 is significantly up regulated in malignant glioma tissues and cell lines. Both loss- and gain-functions assays show that CCND2-AS1 promotes glioma cells proliferation and growth. In addition, we also revealed that highly expressed CCND2-AS1 could enhance Wnt/β-catenin signaling in glioma. Taken together, our findings revealed a novel lncRNA CCND2-AS1 promotes glioma cell proliferation through Wnt/β-catenin signaling and CCND2-AS1 might function as a potential novel therapeutic target for the treatment of glioma.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glioma; LncRNA CCND2-AS1; Wnt/β-catenin signaling

Mesh:

Substances:

Year:  2016        PMID: 27923660     DOI: 10.1016/j.bbrc.2016.12.016

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Long non-coding RNA XIST exerts oncogenic functions in human glioma by targeting miR-137.

Authors:  Zong Wang; Jiangwei Yuan; Li Li; Yang Yang; Xuchang Xu; Ying Wang
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

2.  Fine Mapping of a Major Backfat QTL Reveals a Causal Regulatory Variant Affecting the CCND2 Gene.

Authors:  Haniel C Oliveira; Martijn F L Derks; Marcos S Lopes; Ole Madsen; Barbara Harlizius; Maren van Son; Eli H Grindflek; Marta Gòdia; Arne B Gjuvsland; Pamela Itajara Otto; Martien A M Groenen; Simone E F Guimaraes
Journal:  Front Genet       Date:  2022-05-25       Impact factor: 4.772

3.  LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis.

Authors:  Bin Li; Haikang Zhao; Jianming Song; Fenglu Wang; Mingsheng Chen
Journal:  Hum Cell       Date:  2019-11-12       Impact factor: 4.174

4.  LINC00641/miR-4262/NRGN axis confines cell proliferation in glioma.

Authors:  Jinghui Yang; Duo Yu; Xueshibojie Liu; E Changyong; Shan Yu
Journal:  Cancer Biol Ther       Date:  2020-06-16       Impact factor: 4.742

5.  Non-canonical WNT6/WNT10A signal factor expression in EBV+ post-transplant smooth muscle tumors.

Authors:  Kristin Teiken; Mark Kuehnel; Jan Rehkaemper; Hans Kreipe; Florian Laenger; Kais Hussein; Danny Jonigk
Journal:  Clin Sarcoma Res       Date:  2018-06-04

6.  Prognostic value of long noncoding RNA ZFAS1 in various carcinomas: a meta-analysis.

Authors:  Dan Dong; Zhongyi Mu; Wei Wang; Na Xin; Xiaowen Song; Yue Shao; Chenghai Zhao
Journal:  Oncotarget       Date:  2017-09-20

7.  Aberrant methylation-mediated downregulation of lncRNA CCND2 AS1 promotes cell proliferation in cervical cancer.

Authors:  Chengcheng Zhao; Jian Liu; Huazhang Wu; Jiaojiao Hu; Jianquan Chen; Jie Chen; Fengchang Qiao
Journal:  J Biol Res (Thessalon)       Date:  2020-06-26       Impact factor: 1.889

8.  Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma.

Authors:  Tiago Falcon; Martiela Freitas; Ana Carolina Mello; Laura Coutinho; Mario R Alvares-da-Silva; Ursula Matte
Journal:  Biomed Res Int       Date:  2018-06-26       Impact factor: 3.411

Review 9.  The roles of Wnt/β-catenin signaling pathway related lncRNAs in cancer.

Authors:  Xiao-Yi Hu; Ping-Fu Hou; Teng-Teng Li; Hao-Yu Quan; Min-Le Li; Tian Lin; Jin-Jin Liu; Jin Bai; Jun-Nian Zheng
Journal:  Int J Biol Sci       Date:  2018-11-02       Impact factor: 6.580

10.  A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen.

Authors:  Kang Wang; Jie Li; Yong-Fu Xiong; Zhen Zeng; Xiang Zhang; Hong-Yuan Li
Journal:  Sci Rep       Date:  2018-02-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.